<p>Predicted one year mortality by average imputed CD4 count at antiretroviral therapy initiation assuming a changing mortality among those lost to follow-up depending on CD4 count at ART initiation.</p
<p>Mortality after initiation of antiretroviral treatment stratified by period (2003–2013).</p
<p>Predicted declines in CD4 counts comparing HCV infected individuals to those with similar HIV dur...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...
While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...
<p>Estimated mortality over the first year on antiretroviral therapy as a function of baseline CD4 c...
<p>Modeled changes in CD4 count for surviving patients initiating antire...
<p>Predictors of mortality among all antiretroviral therapy (ART) users and new ART users.</p
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
OBJECTIVE: To determine predictors of mortality and changes in those predictors over time on combina...
BACKGROUND: CD4 count at start of combination antiretroviral therapy (ART) is strongly associated wi...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
<p>Mortality after initiation of antiretroviral treatment stratified by period (2003–2013).</p
<p>Predicted declines in CD4 counts comparing HCV infected individuals to those with similar HIV dur...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...
While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic d...
<p>Estimated mortality over the first year on antiretroviral therapy as a function of baseline CD4 c...
<p>Modeled changes in CD4 count for surviving patients initiating antire...
<p>Predictors of mortality among all antiretroviral therapy (ART) users and new ART users.</p
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
OBJECTIVE: To determine predictors of mortality and changes in those predictors over time on combina...
BACKGROUND: CD4 count at start of combination antiretroviral therapy (ART) is strongly associated wi...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
<p>Mortality after initiation of antiretroviral treatment stratified by period (2003–2013).</p
<p>Predicted declines in CD4 counts comparing HCV infected individuals to those with similar HIV dur...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
DOI
Add to ORKG